Device Trial Radar · NCT03382483
Observational, Non-interventional Use of LIPUS to Mitigate Fracture Non-union in Patients at Risk
Last checked: Nov 20, 2026Latest source record: Oct 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12,387
Actual
Start
Oct 16, 2017
Primary completion
May 26, 2020
Study completion May 1, 2022
Sponsor
- Lead sponsor
- Bioventus LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 26, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is one of three separate studies of the Bioventus Observational Non-interventional EXOGEN Studies (BONES) program. Eligibility for each study is determined by fractured bone.
Conditions
- Mitigation of Fracture Non-union in Patients at Risk
Interventions
Low intensity pulsed ultrasoundDevice
bone growth stimulator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adjunctive treatment with low intensity pulsed ultrasound therapy mitigates the risk of fracture non-union in patients at riskTime frame: 9 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CliniCallRN
Jericho, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.